Journal of Medicinal Chemistry · 2012 · 39 citations · 30 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationEnzyme InhibitionNatural Product-based Drug DesignAntimalarial AgentsAntimalarial Drug DevelopmentEnzyme Inhibitor DiscoveryEnzyme-inhibitor BindingPyrimidine AnalogsPyrimidine AnaloguesPyrimidine BiosynthesisPyrimidine Synthesis Inhibitors
Plasmodium falciparum thymidylate kinase (PfTMPK) is a key enzyme in pyrimidine nucleotide biosynthesis. 3-Trifluoromethyl-4-chloro-phenyl-urea-α-thymidine has been reported as an inhibitor of Mycobacterium tuberculosis TMPK (MtTMPK). Starting from this point, we designed, synthesized and evaluated a number of thymidine analogues as antimalarials. Both 5'-urea-α- and β-thymidine derivatives were moderate inhibitors of PfTMPK and furthermore showed moderate inhibition of parasite growth. The structure of several enzyme-inhibitor complexes provides a basis for improved inhibitor design. However, we found that certain 5'-urea-α-thymidine analogues had antimalarial activity where inhibition of PfTMPK is not the major mode of action. Optimization of this series resulted in a compound with potent antimalarial activity (EC(50) = 28 nM; CC(50) = 29 μM).
30
Overview of the<i>CCP</i>4 suite and current developments
Martyn Winn, Charles Ballard, Kevin Cowtan et al. · Acta Crystallographica Section D Biological Crystallography · 2011 · 12.6K citations · Full text
Genome sequence of the human malaria parasite Plasmodium falciparum
Malcolm J. Gardner, Neil Hall, Eula Fung et al. · Nature · 2002 · 4.5K citations · Full text